- Home
- SFL vs IMTX Comparison
SFL vs IMTX Comparison
Compare SFL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFL | IMTX |
|---|---|---|
| Founded | 2003 | N/A |
| Country | Bermuda | Germany |
| Employees | 24 | 407 |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | SFL | IMTX |
|---|---|---|
| Price | $10.59 | $9.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $12.00 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 1.5M | 519.3K |
| Earning Date | 05-13-2026 | 03-05-2026 |
| Dividend Yield | ★ 7.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.07 | $45.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.73 | $3.30 |
| 52 Week High | $11.28 | $12.41 |
Technical Indicators
Market Signals| Indicator | SFL | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 44.03 |
| Support Level | $9.83 | $9.03 |
| Resistance Level | $11.28 | $10.64 |
| Average True Range (ATR) | 0.28 | 0.56 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 64.17 | 13.04 |
Price Performance
Historical ComparisonAbout SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.